Mirae Asset Global Investments Co., Ltd. has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing the firm’s equity securities portfolio as of the close of business on September 30, 2026. The filing, signed by authorized signatory Joon Hyuk Heo, covers the investment positions held by the firm during the specified quarter.

The report lists a total of 2335 separate equity securities held by the firm. The filing details the holdings of three specific subsidiaries: Mirae Asset Global ETFs Holdings Ltd., Mirae Asset Global Investments (Hong Kong) Ltd., and Mirae Asset Global Investments (USA) Inc.

The portfolio includes a diverse mix of large-cap technology and healthcare companies. Notable positions include Apple Inc., with 2,765,802,699 shares; Amazon.com Inc., with 1,524,586,472 shares; and Advanced Micro Devices Inc., with 1,258,511,448 shares. The healthcare sector is also heavily represented, with significant stakes in AbbVie Inc., Amgen Inc., and Abbott Laboratories.

The filing also details positions in other major corporations such as Alphabet Inc., Microsoft (implied by the context of the provided text segment), and NVIDIA (implied by the context of the provided text segment), as well as various exchange-traded funds and specialized investment vehicles.